Dr. Akgun Ince, MD
522 N New Ballas Rd, Suite 240, Saint Louis, MO 63141 • +1-642-555-8684
Medical Education: Accredited U.S. Medical School (Class of 1994)
What This Doctor Actually Performs: CMS Medicare Utilization & Saint Louis Percentiles
NPI #1053372334 • CBSA Regional • Rheumatology
CMS Medicare Part B utilization records credit Dr. Akgun Ince (MD, NPI 1053372334) at 522 N New Ballas Rd, Suite 240 in Saint Louis with 151,619 annual clinical services (338 beneficiaries), corresponding to a +0.98σ regional deviation and upper-quartile active clinical volume (88.46th Saint Louis percentile) with sub-specialty concentration in 26 Active CMS HCPCS Codes.
Procedural volume for Dr. Ince is led by HCPCS 99214 (Autoimmune Arthritis & Biologic/DMARD Safety Evaluation — 1319 annual services, $45–$62 GPCI cash estimate), followed by CPT 20610 (Large Joint Synovial Arthrocentesis or Corticosteroid Injection, 602/yr) and CPT 96413 (Intravenous Biologic Infusion Therapy (First Hour), 430/yr).
Cash-pay intake data for NPI 1053372334 (522 N New Ballas Rd, Suite 240, Saint Louis) indicates $209.00 typical out-of-pocket visit spend against a $209.00 locality benchmark, paired with 12-minute average reception wait and 4.46/5 biomarker openness.
Credentialed as an MD specialist with 32 years post-graduation experience since completing medical school at an LCME/COCA institution (1994), Dr. Ince coordinates 26 Active CMS HCPCS Codes workups from 522 N New Ballas Rd, Suite 240 (+1-642-555-8684).
Compared against Saint Louis, MO Rheumatology peers
151,619 annual services across 338 beneficiaries
Standard deviations from MO Rheumatology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Autoimmune Arthritis & Biologic/DMARD Safety Evaluation | 1,319 | 88.46th | $45 – $62 |
| 20610 | Large Joint Synovial Arthrocentesis or Corticosteroid Injection | 602 | 93.46th | $36 – $51 |
| 96413 | Intravenous Biologic Infusion Therapy (First Hour) | 430 | 91.46th | $62 – $85 |
| 76881 | Complete Joint Synovitis High-Resolution Ultrasound | 287 | 91.46th | $47 – $65 |
| 99204 | New Patient Autoimmune & Rheumatology Diagnostic Workup | 229 | 85.46th | $62 – $85 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (26 HCPCS billing breadth) | 148,751 | 88.46th | $45 – $65 |
Are you Dr. Akgun Ince? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Saint Louis, MO:
<a href="https://dotmd.com/doctors/akgun-ince-md-saint-louis-mo-1053372334" title="Dr. Akgun Ince, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1053372334.svg" alt="Dr. Akgun Ince Rheumatology Badge" width="280" height="72" /></a>
Dr. Akgun Ince, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Ince National Provider Identifier | NPI #1053372334 (MD) | CMS NPPES Registry (63141) |
| Dr. Ince Saint Louis CMS Volume Rank | 88.46th Pct (151,619 CMS svcs; Z +0.982σ) | CMS Medicare Part B (MO Rheumatology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Saint Louis, MO) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 12 min lobby wait | 26 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.93/5 Listening • 4.46/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Akgun Ince
Other High-Volume Rheumatology Specialists in Saint Louis, MO
Ranked strictly by CMS Medicare volumeDr. Ince Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Saint Louis, MO.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Akgun Ince community threads and patient logs by age, biological sex, dosage, and treatment duration.